Table 2 Parasitological characteristics of cross-sectional survey participants.

From: Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention

Variable

 

Overall N = 1199

2 to < 5 years N = 155

5 to < 10 years N = 244

10 to < 15 years N = 150

15 to < 20 years N = 117

 > 20 years N = 533

Plasmodium infection

P. falciparum

n (%)

393 (32.8)

36 (23.2)

131 (53.7)

85 (56.7)

44 (37.6)

97 (18.2)

P. malariae

n (%)

9 (0.8)

0

7 (2.9)

1 (0.7)

0

1 (0.2)

Mixed infection (P. falciparum + P. malariae)

n (%)

20 (1.7)

2 (1.3)

12 (4.9)

4 (2.7)

1 (0.9)

1 (0.2)

P. ovale

n (%)

0

0

0

0

0

0

P. vivax

n(%)

0

0

0

0

0

0

P. falciparum high density (> 5,000 parasites/µL) prevalence, detected by microscopy

n (%)

40 (3.3)*

14 (9.0)

22 (9.0)

4 (2.7)

0

0

Geometric mean of P. falciparum density per μL

(95%CI)

573.5 (491.0–669.7)

3333.9 (1924.2–5776.3)

882.0 (682.7–1139.5)

507.9 (385.9–668.4)

294.9 (200.6–433.6)

234.3 (182.6–300.6)

Gametocyte prevalence P.f (any density)

n (%)

57 (4.8)

12 (7.7)

17 (7.0)

10 (6.7)

3 (2.6)

15 (2.8)

Geometric mean P.f gametocytes density per μL

(95% CI)

31.3 (22.8–43.0)

66.1 (25.1–174.3)

40.2 (21.1–76.6)

20.6 (10.1–41.9)

35.4 (11.6–108.4)

16.7 (12.0–23.3)

Fever

(body temperature ≥ 37.5 °C or history of fever in the previous 48 h)

n (%)

80 (6.7)

8 (5.2)

14 (5.7)

13 (8.7)

5 (4.3)

40 (7.5)

Prevalence of symptomatic P. falciparum malaria (fever + microscopy positive)

n (%)

32 (2.7)

3 (1.9)

9 (3.7)

9 (6.0)

3 (2.6)

8 (1.5)

Prevalence of asymptomatic P. falciparum infection

n (%)

361 (30.1)

33 (21.3)

122 (50.0)

76 (50.7)

41 (35.0)

89 (16.7)

  1. *2/40 were mixed P.f/P.m infections.